Skip to main content
Erschienen in: Digestive Diseases and Sciences 4/2023

20.09.2022 | Original Article

Stratification Based on Risk Factors at Diagnosis Could Predict Progression in Patients with Pancreatic Cysts

verfasst von: Ryo Sugio, Tsutomu Nishida, Kengo Matsumoto, Kosuke Kawamura, Miyoung Park, Tomoya Hamabe, Kana Hosokawa, Shinji Kuriki, Li-sa Chang, Yoshifumi Fujii, Naoto Osugi, Aya Sugimoto, Kaori Mukai, Dai Nakamatsu, Shiro Hayashi, Masashi Yamamoto, Sachiko Nakajima, Koji Fukui, Masami Inada

Erschienen in: Digestive Diseases and Sciences | Ausgabe 4/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Predicting the risk of malignant transformation in pancreatic cyst patients is challenging.

Aim

We retrospectively investigated the risk factors for malignant transformation in pancreatic cyst patients.

Methods

Patients with pancreatic cysts diagnosed using imaging tests were followed from November 2008 to December 2021. A significant change was defined as the additional development of high-risk stigmata (HRS), worrisome features (WFs), or pancreatic cancer during monitoring.

Results

In total, 479 patients were analyzed, with a median observation period of 50 months. Forty-four patients (9.2%) showed significant changes, and eight (1.7%) developed pancreatic cancer. The univariate analysis showed that the cyst diameter at diagnosis (≥ 14 mm), main pancreatic duct (MPD) diameter at diagnosis (≥ 3 mm), presence of multilocular cysts, and an inconsistent MPD caliber were significant predictive factors for a significant change. One point was assigned for each significant factor. We grouped the patients into three groups: the low-risk group (total score 0), medium-risk group (score 1–2), and high-risk group (score 3–4). The high-risk group had a higher risk of a significant change than the medium- and low-risk groups (age-adjusted HRs for the medium-risk and high-risk groups were 3.0 and 5.2 compared with the low-risk group).

Conclusion

Stratification based on risk factors may help predict the development of significant changes in pancreatic cyst patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Chang YR, Park JK, Jang JY, Kwon W, Yoon JH, Kim SW. Incidental pancreatic cystic neoplasms in an asymptomatic healthy population of 21,745 individuals: Large-scale, single-center cohort study. Medicine (Baltimore). 2016;95:e5535.CrossRefPubMedPubMedCentral Chang YR, Park JK, Jang JY, Kwon W, Yoon JH, Kim SW. Incidental pancreatic cystic neoplasms in an asymptomatic healthy population of 21,745 individuals: Large-scale, single-center cohort study. Medicine (Baltimore). 2016;95:e5535.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Kromrey ML, Bülow R, Hübner J et al. Prospective study on the incidence, prevalence and 5-year pancreatic-related mortality of pancreatic cysts in a population-based study. Gut. 2018;67:138–145.CrossRefPubMed Kromrey ML, Bülow R, Hübner J et al. Prospective study on the incidence, prevalence and 5-year pancreatic-related mortality of pancreatic cysts in a population-based study. Gut. 2018;67:138–145.CrossRefPubMed
3.
Zurück zum Zitat Lee KS, Sekhar A, Rofsky NM, Pedrosa I. Prevalence of incidental pancreatic cysts in the adult population on MR imaging. Am J Gastroenterol. 2010;105:2079–2084.CrossRefPubMed Lee KS, Sekhar A, Rofsky NM, Pedrosa I. Prevalence of incidental pancreatic cysts in the adult population on MR imaging. Am J Gastroenterol. 2010;105:2079–2084.CrossRefPubMed
4.
Zurück zum Zitat Sun L, Wang Y, Jiang F, Qian W, Shao C, Jin Z. Prevalence of pancreatic cystic lesions detected by magnetic resonance imaging in the Chinese population. J Gastroenterol Hepatol. 2019;34:1656–1662.CrossRefPubMed Sun L, Wang Y, Jiang F, Qian W, Shao C, Jin Z. Prevalence of pancreatic cystic lesions detected by magnetic resonance imaging in the Chinese population. J Gastroenterol Hepatol. 2019;34:1656–1662.CrossRefPubMed
5.
Zurück zum Zitat Basturk O, Hong SM, Wood LD et al. A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas. Am J Surg Pathol. 2015;39:1730–1741.CrossRefPubMedPubMedCentral Basturk O, Hong SM, Wood LD et al. A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas. Am J Surg Pathol. 2015;39:1730–1741.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Tanaka M, Fernandez-Del Castillo C, Kamisawa T et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology. 2017;17:738–753.CrossRefPubMed Tanaka M, Fernandez-Del Castillo C, Kamisawa T et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology. 2017;17:738–753.CrossRefPubMed
7.
Zurück zum Zitat Vege SS, Ziring B, Jain R, Moayyedi P, Clinical Guidelines C, American Gastroenterology A. American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology. 2015;148:819–22; quize12–3. Vege SS, Ziring B, Jain R, Moayyedi P, Clinical Guidelines C, American Gastroenterology A. American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology. 2015;148:819–22; quize12–3.
8.
Zurück zum Zitat Elta GH, Enestvedt BK, Sauer BG, Lennon AM. ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts. Am J Gastroenterol. 2018;113:464–479.CrossRefPubMed Elta GH, Enestvedt BK, Sauer BG, Lennon AM. ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts. Am J Gastroenterol. 2018;113:464–479.CrossRefPubMed
9.
Zurück zum Zitat European Study Group on Cystic Tumours of the P. European evidence-based guidelines on pancreatic cystic neoplasms. Gut. 2018;67:789–804. European Study Group on Cystic Tumours of the P. European evidence-based guidelines on pancreatic cystic neoplasms. Gut. 2018;67:789–804.
10.
Zurück zum Zitat Park HW, Lee JS, Park SY et al. Progression of pancreatic cystic lesions without any risk features is associated with initial cyst size and obesity. J Gastroenterol Hepatol 2020;35:877–884.CrossRefPubMed Park HW, Lee JS, Park SY et al. Progression of pancreatic cystic lesions without any risk features is associated with initial cyst size and obesity. J Gastroenterol Hepatol 2020;35:877–884.CrossRefPubMed
11.
Zurück zum Zitat Pergolini I, Sahora K, Ferrone CR et al. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center. Gastroenterology 2017;153:1284–94.e1.CrossRefPubMed Pergolini I, Sahora K, Ferrone CR et al. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center. Gastroenterology 2017;153:1284–94.e1.CrossRefPubMed
12.
Zurück zum Zitat Marchegiani G, Pollini T, Andrianello S, Tomasoni G, Biancotto M, Javed AA et al. Progression vs Cyst Stability of Branch-Duct Intraductal Papillary Mucinous Neoplasms After Observation and Surgery. JAMA Surg. 2021;156:654–661.CrossRefPubMedPubMedCentral Marchegiani G, Pollini T, Andrianello S, Tomasoni G, Biancotto M, Javed AA et al. Progression vs Cyst Stability of Branch-Duct Intraductal Papillary Mucinous Neoplasms After Observation and Surgery. JAMA Surg. 2021;156:654–661.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Yamaguchi K, Ohuchida J, Ohtsuka T, Nakano K, Tanaka M. Intraductal papillary-mucinous tumor of the pancreas concomitant with ductal carcinoma of the pancreas. Pancreatology 2002;2:484–490.CrossRefPubMed Yamaguchi K, Ohuchida J, Ohtsuka T, Nakano K, Tanaka M. Intraductal papillary-mucinous tumor of the pancreas concomitant with ductal carcinoma of the pancreas. Pancreatology 2002;2:484–490.CrossRefPubMed
14.
Zurück zum Zitat Fahrmann JF, Schmidt CM, Mao X et al. Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection. Gastroenterology 2021;160:1373–83.e6.CrossRefPubMed Fahrmann JF, Schmidt CM, Mao X et al. Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection. Gastroenterology 2021;160:1373–83.e6.CrossRefPubMed
Metadaten
Titel
Stratification Based on Risk Factors at Diagnosis Could Predict Progression in Patients with Pancreatic Cysts
verfasst von
Ryo Sugio
Tsutomu Nishida
Kengo Matsumoto
Kosuke Kawamura
Miyoung Park
Tomoya Hamabe
Kana Hosokawa
Shinji Kuriki
Li-sa Chang
Yoshifumi Fujii
Naoto Osugi
Aya Sugimoto
Kaori Mukai
Dai Nakamatsu
Shiro Hayashi
Masashi Yamamoto
Sachiko Nakajima
Koji Fukui
Masami Inada
Publikationsdatum
20.09.2022
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 4/2023
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-022-07699-y

Weitere Artikel der Ausgabe 4/2023

Digestive Diseases and Sciences 4/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.